IRRERA, Natasha
 Distribuzione geografica
Continente #
EU - Europa 4.082
NA - Nord America 3.515
AS - Asia 1.118
AF - Africa 8
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 8.737
Nazione #
US - Stati Uniti d'America 3.492
IE - Irlanda 1.003
IT - Italia 999
SE - Svezia 825
PL - Polonia 671
CN - Cina 523
SG - Singapore 393
DE - Germania 130
FI - Finlandia 116
GB - Regno Unito 95
UA - Ucraina 68
IN - India 66
ID - Indonesia 53
BE - Belgio 52
VN - Vietnam 47
AT - Austria 36
FR - Francia 35
CZ - Repubblica Ceca 25
CA - Canada 22
RU - Federazione Russa 11
KR - Corea 10
HK - Hong Kong 5
NL - Olanda 5
JP - Giappone 4
RO - Romania 4
AU - Australia 3
BR - Brasile 3
CL - Cile 3
EG - Egitto 3
EU - Europa 3
IL - Israele 3
IR - Iran 2
KE - Kenya 2
KH - Cambogia 2
MA - Marocco 2
MY - Malesia 2
SI - Slovenia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CH - Svizzera 1
CO - Colombia 1
EC - Ecuador 1
ES - Italia 1
GH - Ghana 1
JO - Giordania 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
PA - Panama 1
QA - Qatar 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 8.737
Città #
Dublin 1.003
Chandler 771
Warsaw 671
Messina 446
Nyköping 445
Singapore 317
Ashburn 284
Jacksonville 202
Beijing 152
Ann Arbor 147
Dearborn 144
Princeton 138
Medford 131
New York 114
Cambridge 97
Des Moines 95
Boardman 86
Rome 68
Wilmington 63
Jakarta 53
Brussels 51
Munich 48
Dong Ket 47
Los Angeles 43
San Mateo 42
Lancaster 40
Woodbridge 40
Jinan 39
Shenyang 39
Vienna 36
Houston 34
Helsinki 33
Pune 31
Hyderabad 29
Nanjing 27
Seattle 25
Fairfield 24
Brno 23
Taizhou 20
Haikou 19
Tianjin 19
Ningbo 18
Washington 17
Guangzhou 16
Ottawa 16
Trecastagni 16
Catania 15
Hebei 15
Zhengzhou 15
Caltagirone 14
Falls Church 14
Bremen 12
Redmond 12
San Filippo 12
Nanchang 11
Padova 11
Taiyuan 11
Jiaxing 9
Fuzhou 8
Hangzhou 8
Lanzhou 8
Reggio Calabria 8
London 7
Milan 7
Augusta 6
Chicago 6
Leawood 6
Santa Clara 6
Scandicci 6
Tappahannock 6
Aci Sant'antonio 5
Changsha 5
Clearwater 5
Lamezia Terme 5
Lappeenranta 5
Norwalk 5
Paris 5
San Giovanni La Punta 5
Cagliari 4
Carini 4
Enna 4
Kunming 4
Mountain View 4
Nuremberg 4
Auburn Hills 3
Bologna 3
Boston 3
Capo D'orlando 3
Fiumefreddo Di Sicilia 3
Fremont 3
Hefei 3
Kemerovo 3
Misterbianco 3
Montreal 3
Palermo 3
Piazza Armerina 3
Pompei 3
Scordia 3
Torino 3
Alexandria 2
Totale 6.563
Nome #
ADENOSINE RECEPTORS AS STRATEGIC TARGETS FOR THE DESIGN AND DEVELOPMENT OF INNOVATIVE DRUGS FOR THE MANAGEMENT OF SPINAL CORD INJURY 236
Pharmacological activity and clinical use of PDRN 192
Adenosine Receptor Stimulation by Polydeoxyribonucleotide Improves Tissue Repair and Symptomology in Experimental Colitis. 130
β-Caryophyllene Mitigates Collagen Antibody Induced Arthritis (CAIA) in Mice Through a Cross-Talk between CB2 and PPAR-γ Receptors 127
Flavocoxid, a Natural Antioxidant, Protects Mouse Kidney from Cadmium-Induced Toxicity. 124
Polydeoxyribonucleotide, an adenosine-A2A receptor agonist, preserves blood testis barrier from cadmium-induced injury 123
Epoetin Alpha and Epoetin Zeta: A Comparative Study on Stimulation of Angiogenesis and Wound Repair in an Experimental Model of Burn Injury 121
Evidence for a role of mitogen-activated protein kinases in the treatment of experimental acute pancreatitis. 116
Activation of A2A receptor by PDRN Reduces neuronal damage and stimulates WNT/β-CATENIN driven neurogenesis in spinal cord injury 115
BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis 109
ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury 108
Blockade of the JNK signalling as a rational therapeutic approach to modulate the early and late steps of the inflammatory cascade in polymicrobial sepsis 107
Lack of the Nlrp3 inflammasome improves mice recovery following traumatic brain injury 105
A dual inhibitor of cyclooxygenase and 5-lipoxygenase protects against kainic acid-induced brain injury. 104
Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose–Effect Relationships in an Experimental In Vitro Model of Osteoarthritis 103
null 102
Oxidative Stress: Harms and Benefits for Human Health 101
Apoptotic pathways linked to endocrine system as potential therapeutic targets for benign prostatic hyperplasia 98
Adenosine receptor stimulation improves glucocorticoid-induced osteoporosis in a rat model 92
Role of Inhibitors of Apoptosis Proteins in Testicular Function and Male Fertility: Effects of Polydeoxyribonucleotide Administration in Experimental Varicocele 92
Melanocortin 4 receptor stimulation decreases pancreatitis severity in rats by activation of the cholinergic anti-inflammatory pathway. 91
CO2 Pneumoperitoneum Preserves -Arrestin 2 Content and Reduces High Mobility Group Box-1 (HMGB-1) Expression in an Animal Model of Peritonitis 90
Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma cells 88
Effects of Myo-inositol Alone and in Combination with Seleno-L-methionine on Cadmium-Induced Testicular Damage in Mice 88
NLRP3 Inflammasome Involvement in the Organ Damage and Impaired Spermatogenesis Induced by Testicular Ischemia and Reperfusion in Mice 87
Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate 85
null 83
CO(2) pneumoperitoneum impact on early liver and lung cytokine expression in a rat model of abdominal sepsis. 81
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 81
Activation of the EPOR-β common receptor complex by cibinetide ameliorates impaired wound healing in mice with genetic diabetes 80
Cadmium-induced oxidative stress impairs glycemic control in adolescents 80
Nutraceutical Effects of Lycopene in Experimental Varicocele: An “In Vivo” Model to Study Male Infertility 79
Activation of adenosine A2(A) receptors restores the altered cell-cycle machinery during impaired wound healing in genetically diabetic mice 78
Activation of adenosine A2A receptors by polydeoxyribonucleotide increases vascular endothelial growth factor and protects against testicular damage induced by experimental varicocele in rats. 78
Melanocortin 4 receptor activation protects against testicular ischemia-reperfusion injury by triggering the cholinergicantiinflammatory pathway 74
Effects of the antagomiRs 15b and 200b on the altered healing pattern of diabetic mice 74
The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice. 73
Protective effects of melanocortins on short-term changes in a rat model of traumatic brain injury 72
Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A(2A) receptor 72
null 71
Myo-inositol in the protection from cadmium-induced toxicity in mice kidney: An emerging nutraceutical challenge 71
2017 ACR/ARHP Annual Meeting Abstract Supplement 70
Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis. 69
Polydeoxyribonucleotide (PDRN): a safe approach to induce therapeutic angiogenesis in peripheral artery occlusive disease and in diabetic foot ulcers. 68
Dietary management of skin health: The role of genistein 68
null 67
Cadmium delays puberty onset and testis growth in adolescents 67
Protective Effects of Myo-Inositol and Selenium on Cadmium-Induced Thyroid Toxicity in Mice 67
Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis. 64
Evidence for using a dual COX 1/2 and 5-LOX inhibitor in neurodegenerative diseases 64
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 62
Effects of Soy Isoflavone Genistein Aglycone On Skin Changes Induced By Experimental Menopause : A Comparison With Estradiol And Raloxifene 61
Systemic administration of high-molecular weight hyaluronan stimulates wound healing in genetically diabetic mice 61
Blockade of the Adenosine 2A Receptor Mitigates the Cardiomyopathy Induced by Loss of Plakophilin-2 Expression 60
Anti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude 60
FLAVOCOXID, A DUAL INHIBITOR OF COX-2 AND 5-LOX, REDUCES PANCREATIC DAMAGE IN AN EXPERIMENTAL MODEL OF ACUTE PANCREATITIS. 59
Adenosine receptor stimulation by polynucleotides (PDRN) reduces inflammation in experimental periodontitis. 58
Targeting Adenosine Receptor by Polydeoxyribonucleotide: An Effective Therapeutic Strategy to Induce White-to-Brown Adipose Differentiation and to Curb Obesity 57
Peroxisome proliferator activated receptor beta/delta activation prevents extracellular regulated kinase 1/2 phosphorylation and protects the testis from ischemia and reperfusion injury. 56
GENISTEIN AGLYCONE DEMONSTRATES A PROTECTIVE AND REVERSIBLE EFFECT ON THE DEVELOPMENT OF STEROID-INDUCED SECONDARY OSTEOPOROSIS AND INCREASES BONE BREAKING STRENGHT IN VIVO 56
Preclinical and clinical applications of biomaterials in the enhancement of wound healing in oral surgery: An overview of the available reviews 55
GENISTEIN AGLYCONE IMPROVES SKIN REPAIR IN AN INCISIONAL MODEL OF WOUND HEALING: A COMPARISON WITH RALOXIFENE AND OESTRADIOL IN OVARIECTOMIZED RATS 54
Differential Expression of Nitric Oxide Synthase Isoforms nNOS and iNOS in Patients with Non-Segmental Generalized Vitiligo 54
Health potential of aloe vera against oxidative stress induced corneal damage: An “in vitro” study 54
Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments 54
Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia. 53
A 7-Years Active Pharmacovigilance Study of Adverse Drug Reactions Causing Children Admission to a Pediatric Emergency Department in Sicily 53
NLRP3 Inflammasome: A New Pharmacological Target for Reducing Testicular Damage Associated with Varicocele 53
Reduction of oxidative stress blunts the NLRP3 inflammatory cascade in LPS stimulated human gingival fibroblasts and oral mucosal epithelial cells 53
Fibrosis after Myocardial Infarction: An Overview on Cellular Processes, Molecular Pathways, Clinical Evaluation and Prognostic Value 53
Biglycan Involvement in Heart Fibrosis: Modulation of Adenosine 2A Receptor Improves Damage in Immortalized Cardiac Fibroblasts 52
GENISTEIN AGLYCONE: A DUAL MODE OF ACTION ANTI-OSTEOPOROTIC SOY ISOFLAVONE REBALANCING BONE TURNOVER TOWARDS BONE FORMATION 52
Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis 52
PDRN, a natural bioactive compound, blunts inflammation and positively reprograms healing genes in an “in vitro” model of oral mucositis 52
Genistein aglycone, a soy-derived isoflavone, improves skin changes induced by ovariectomy in rats 51
Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice 51
Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing 51
Correction: Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis 50
Survivin and NAIP in Human Benign Prostatic Hyperplasia: Protective Role of the Association of Serenoa repens, Lycopene and Selenium from the Randomized Clinical Study 50
The Association of Myo-Inositol and Selenium Contrasts Cadmium-Induced Thyroid C Cell Hyperplasia and Hypertrophy in Mice 50
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone 49
AB0198 Cilengitide Modulates Pulmonary Cell Proliferation in the Reactive Oxygen Species Murine Model of Systemic Sclerosis 49
Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis 49
Simvastatin attenuates the development of pulmonary and cutaneous fibrosis in a murine model of systemic sclerosis. 49
MAo-A inhibition by metaxalone reverts IL-1β-induced inflammatory phenotype in microglial cells 49
Influence of polymorphism -308 G/A of the TNF-α gene on high mobility group BOX-1 protein in rheumatoid and spondylo-arthritis patients 48
Failure of Achieving Tacrolimus Target Blood Concentration Might Be Avoided by a Wide Genotyping of Transplanted Patients: Evidence from a Retrospective Study 48
Combined treatment with polynucleotides and hyaluronic acid improves tissue repair in experimental colitis 48
Effect of Serenoa repens, Lyocopene, and Selenium on Proinflammatory I kappa B-alpha Phenotype Activation: An In Vitro And In Vivo Comparison Study 47
The combination of Serenoa repens, selenium and lycopene ismore effective than Serenoa repens alone to prevent hormonedependent prostatic growth 47
Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene 47
Administration of a Nutraceutical Mixture Composed by Aloe arborescens, Annona muricata, Morinda citrifolia, Beta rubra, Scutellaria baicalensis, and Vaccinium myrtillus Reduces Doxorubicin-Induced Side Effects 47
Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions 47
The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis 47
β-caryophyllene inhibits cell proliferation through a direct modulation of CB2 receptors in glioblastoma cells 46
Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways 46
Emerging Evidence and Treatment Perspectives from Randomized Clinical Trials in Systemic Sclerosis: Focus on Interstitial Lung Disease 46
Simvastatin prevents vascular complications in the chronic reactive oxygen species murine model of systemic sclerosis 45
Simvastatin Attenuates Pulmonary Fibrosis in a Murine Model of Systemic Sclerosis. 44
Serenoa repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia. 44
Totale 7.264
Categoria #
all - tutte 40.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.391


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020726 0 0 0 0 8 147 83 58 23 163 110 134
2020/20211.565 104 84 334 91 170 81 101 65 187 209 70 69
2021/20221.305 13 191 30 51 78 31 109 60 27 250 113 352
2022/20232.882 209 301 135 204 180 309 24 175 1.212 18 77 38
2023/20241.155 50 123 97 129 73 238 28 45 6 158 60 148
2024/2025718 121 54 88 277 178 0 0 0 0 0 0 0
Totale 9.342